Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Gastroenterology|November 21, 2015
Risk of Advanced Adenomas in Siblings of Individuals With Advanced Adenomas: A Cross-Sectional StudySiew C Ng, James Y W Lau, Francis K L Chan, et al.
Gut|December 20, 2014
Comparison of colonoscopic performance between medical and nurse endoscopists: a non-inferiority randomised controlled study in AsiaAric J Hui, James Y Lau, Phyllis P Y Lam, et al.
Lancet (London, England)|April 16, 2017
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trialFrancis K L Chan, Jessica Y L Ching, Yee Kit Tse, et al.
Cell Host & Microbe|April 24, 2024
The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndromeQi Su, Raphaela I Lau, Qin Liu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|July 1, 2022
Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort StudyJoyce W Y Mak, Sun Yang, Annalise Stanley, et al.
Nature Communications|November 10, 2022
Faecal microbiome-based machine learning for multi-class disease diagnosisQi Su, Qin Liu, Raphaela Iris Lau, et al.
The American Journal of Gastroenterology|March 16, 2016
Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific RegionsMartin C S Wong, Jessica Y L Ching, Han-Mo Chiu, et al.
The Lancet. Infectious Diseases|December 10, 2023
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trialRaphaela I Lau, Qi Su, Ivan S F Lau, et al.
Gut|April 8, 2026
Quantifying artificial sweeteners and emulsifiers in Crohn's disease and its relationship with disease activity: the ENIGMA study - a novel and targeted approachJingwan Zhang, Jielun Hu, Xinyi Tang, et al.
Gastroenterology|September 20, 2016
Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose AspirinFrancis K L Chan, Moe Kyaw, Tetsuya Tanigawa, et al.
Pageof 10